• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma.复杂腺泡模式作为肺腺癌生存概率的独立预测指标。
Transl Lung Cancer Res. 2022 Sep;11(9):1739-1741. doi: 10.21037/tlcr-22-513.
2
Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.在调整了第八版 TNM 分期系统后，筛状亚型是肺腺癌患者术后复发和生存的独立预测因子。
J Thorac Oncol. 2019 Feb;14(2):245-254. doi: 10.1016/j.jtho.2018.09.028. Epub 2018 Oct 15.
3
Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern.原发性肺腺癌组织学模式的观察者间可重复性研究，重点关注一种不同于典型腺泡模式的更复杂腺管模式。
Int J Surg Pathol. 2014 Apr;22(2):149-55. doi: 10.1177/1066896913519165. Epub 2014 Jan 29.
4
Prominent Nucleoli and Non-glandular Feature Are Independent Predictors of PD-L1 Expression in Lung Adenocarcinoma.显著核仁与非腺特征是肺腺癌中PD-L1表达的独立预测因素。
Anticancer Res. 2018 Oct;38(10):6003-6008. doi: 10.21873/anticanres.12949.
5
Spread through air spaces is an independent predictor of recurrence in stage III (N2) lung adenocarcinoma.在Ⅲ期（N2）肺腺癌中，通过气腔播散是复发的独立预测因素。
Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):442-448. doi: 10.1093/icvts/ivz116.
6
Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.浸润性肺腺癌中复杂腺体形态的预后价值。
Hum Pathol. 2022 Oct;128:56-68. doi: 10.1016/j.humpath.2022.07.007. Epub 2022 Jul 22.
7
Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.鳞屑状和微乳头生长模式以及Napsin A的表达可将Ⅰ期肺腺癌患者分层为不同的预后亚组。
Int J Clin Exp Pathol. 2014 Mar 15;7(4):1459-68. eCollection 2014.
8
Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma.肺腺癌复杂腺泡模式的突变特征及预后意义的综合分析
Transl Lung Cancer Res. 2022 Jul;11(7):1337-1347. doi: 10.21037/tlcr-22-127.
9
Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.辅助化疗可提高IB期肺腺癌切除患者无复发生存的概率。
Ann Thorac Surg. 2016 Apr;101(4):1346-53. doi: 10.1016/j.athoracsur.2015.10.075. Epub 2016 Jan 12.
10
Prognostic significance of grading in lung adenocarcinoma.肺腺癌分级的预后意义。
Cancer. 2010 Feb 1;116(3):659-69. doi: 10.1002/cncr.24831.

本文引用的文献

1
Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma.肺腺癌复杂腺泡模式的突变特征及预后意义的综合分析
Transl Lung Cancer Res. 2022 Jul;11(7):1337-1347. doi: 10.21037/tlcr-22-127.
2
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.侵袭性肺腺癌分级系统：国际肺癌研究协会病理学委员会的建议。
J Thorac Oncol. 2020 Oct;15(10):1599-1610. doi: 10.1016/j.jtho.2020.06.001. Epub 2020 Jun 17.
3
Overall Survival with Osimertinib in Untreated, -Mutated Advanced NSCLC.奥希替尼治疗未经治、-突变型晚期 NSCLC 的总生存期。
N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21.
4
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component.奥希替尼治疗预处理 T790M 阳性的晚期非小细胞肺癌：AURA 研究二期扩展部分。
J Clin Oncol. 2017 Apr 20;35(12):1288-1296. doi: 10.1200/JCO.2016.70.3223. Epub 2017 Feb 21.
5
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.奥希替尼治疗预处理 EGFR Thr790Met 阳性的晚期非小细胞肺癌（AURA2）：一项多中心、开放标签、单臂、2 期研究。
Lancet Oncol. 2016 Dec;17(12):1643-1652. doi: 10.1016/S1470-2045(16)30508-3. Epub 2016 Oct 14.
6
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.非小细胞肺癌患者中表皮生长因子受体（EGFR）突变的患病率：一项系统评价和荟萃分析。
Oncotarget. 2016 Nov 29;7(48):78985-78993. doi: 10.18632/oncotarget.12587.
7
Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.肺腺癌筛状模式的预后影响和临床病理相关性。
J Thorac Oncol. 2015 Apr;10(4):638-44. doi: 10.1097/JTO.0000000000000490.
8
Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma.筛状和融合腺体是高级别肺腺癌的一种模式。
Hum Pathol. 2014 Feb;45(2):213-20. doi: 10.1016/j.humpath.2013.10.011. Epub 2013 Oct 23.
9
Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib.表皮生长因子受体体细胞突变蛋白的动力学分析表明，其对表皮生长因子受体酪氨酸激酶抑制剂厄洛替尼的敏感性增加。
Cancer Res. 2006 Aug 15;66(16):8163-71. doi: 10.1158/0008-5472.CAN-06-0453.
10
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.表皮生长因子受体的外显子19缺失突变与接受吉非替尼或厄洛替尼治疗的非小细胞肺癌患者的生存期延长相关。
Clin Cancer Res. 2006 Jul 1;12(13):3908-14. doi: 10.1158/1078-0432.CCR-06-0462.

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma.

作者信息

Hydbring Per

机构信息

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Transl Lung Cancer Res. 2022 Sep;11(9):1739-1741. doi: 10.21037/tlcr-22-513.

DOI:10.21037/tlcr-22-513
PMID:36248342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9554688/
Abstract
摘要